Remove Biosimilars Remove Pharmaceutical Manufacturing Remove Prescription Filling
article thumbnail

January 2025 Newsletter

Safe Biologics

The consequences of the IRAs small molecule penalty, which limits the time manufacturers have to recoup investments in simpler small molecule drugs like pills, are already being felt. Small molecule drugs make up over 90% of prescriptions filled in the U.S. Read the full statement here.